CIK 0001528115
- Non-accelerated filer
- Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275414423
- Phone
- +1 650-822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-11 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Exercise or conversion 10b5-1 | +30,646 | $1.85 | $57K | 184,807 |
| 2026-06-11 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −30,646 | 0 | ||
| 2026-03-02 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −5,566 | $5.42 | $30K | 154,161 |
| 2026-02-19 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award | +62,500 | 159,727 | ||
| 2026-02-19 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2026-02-18 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −7,857 | $5.11 | $40K | 97,227 |
| 2025-07-14 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −1,116 | $2.58 | $3K | 105,084 |
| 2025-02-27 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award · Stock Option (Right to Buy) | +272,575 | 272,575 | ||
| 2025-02-18 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −8,345 | $2.91 | $24K | 61,237 |
| 2025-02-13 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −1,783 | $2.99 | $5K | 69,582 |
| 2024-10-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Exercise or conversion 10b5-1 | +5,408 | $1.85 | $10K | 76,773 |
| 2024-10-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,408 | $7.41 | $40K | 71,365 |
| 2024-10-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −5,408 | 30,646 | ||
| 2024-09-19 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −4,500 | $7.10 | $32K | 0 |
| 2024-09-12 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,500 | $6.16 | $34K | 4,500 |
| 2024-09-05 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,500 | $5.64 | $31K | 10,000 |
| 2024-08-29 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale 10b5-1 | −5,500 | $5.95 | $33K | 15,500 |
| 2024-07-15 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −1,106 | $6.02 | $7K | 71,365 |
| 2024-02-27 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award | +44,963 | 106,200 | ||
| 2024-02-20 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −2,604 | $5.51 | $14K | 72,471 |
Page 1 of 3 · 49 trades